Nurix Therapeutics, Inc. · NASDAQ:NRIX
Perceptive Advisors LLC reported a 5.30% stake in Nurix Therapeutics, Inc. (Schedule 13G)
Event Sep 16, 2026 · Filed Sep 23, 2026
Perceptive Advisors LLC reported a 5.30% stake in Nurix Therapeutics, Inc., 5,536,629 shares, as a passive investor on Sep 16, 2026. Filed Sep 23, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 5,536,629
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 5.30% | 5,536,629 |
| Joseph Edelman | 5.30% | 5,536,629 |
| Perceptive Life Sciences Master Fund, Ltd. | 5.30% | 5,536,629 |
Source
Related
- Nurix Therapeutics, Inc.
- Perceptive Advisors LLC
- Nurix Therapeutics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · Nov 16, 2026
- Schedule 13G/A · Rubric Capital Management LP · Nov 16, 2026
- Schedule 13G/A · Deep Track Capital, LP · Nov 16, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Nov 16, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Nov 16, 2026
- Schedule 13G/A · FMR LLC · Nov 5, 2026